John has extensive experience in the life sciences sector. He is Chairman of Synpromics Ltd, BioCity Group and the Cell and Gene Therapy Catapult. Previously he was Chairman of Kyowa Kirin International plc, BTG plc, Axis-Shield plc, Touch Bionics Ltd and CXR Biosciences Ltd and a Non-Executive Director of Quantum Pharma plc. In the public sector, he is Chairman of the Roslin Foundation, a Fellow, Trustee and Treasurer of the Royal Society of Edinburgh, a Member of MRC Council and an Honorary Professor of the University of Edinburgh. He was made CBE in 2011. John joined the board of Acacia Pharma in 2018.